Blood cancers, Leukaemia, Lymphoma
Results
Phase 1
This trial was done to find out if vaccines can increase the to certain proteins in the body. And if that can affect how well work.
The first step was to find out what happens in people who don’t have cancer (healthy volunteers). Researchers then hope to give these vaccines to people who are going to donate their to people with leukaemia or lymphoma.
The trial was open for people to join between 2012 and 2017. The team published the results in 2021.
Recruitment start: 1 December 2012
Recruitment end: 2 February 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Paul Moss
Bloodwise
Cancer Research UK Clinical Trials Unit Birmingham
Experimental Cancer Medicine Centre (ECMC)
University of Birmingham
Last reviewed: 5 August 2024
CRUK internal database number: 7446